Gao L, Zheng C, Tian T, Brima Tia A, Abdulai M, Xiao K
Front Public Health. 2025; 13:1526727.
PMID: 40051513
PMC: 11882590.
DOI: 10.3389/fpubh.2025.1526727.
Kaplan B, Pavel S, Uygut M, Tunc M, Eroksuz Y, Celik I
Vaccines (Basel). 2025; 13(2).
PMID: 40006716
PMC: 11861512.
DOI: 10.3390/vaccines13020169.
Maree G, Els F, Naidoo Y, Naidoo L, Mahamuza P, Macheke M
PLoS One. 2025; 20(2):e0311332.
PMID: 39999204
PMC: 11856519.
DOI: 10.1371/journal.pone.0311332.
Yu C, Wang W, Zhang Q, Jin Z
Front Immunol. 2025; 16:1510770.
PMID: 39958350
PMC: 11825795.
DOI: 10.3389/fimmu.2025.1510770.
Bhiman J, Madzorera V, Mkhize Q, Scheepers C, Hermanus T, Ayres F
Sci Rep. 2025; 15(1):5549.
PMID: 39953108
PMC: 11828959.
DOI: 10.1038/s41598-025-89940-y.
Two Years of SARS-CoV-2 Omicron Genomic Evolution in Brazil (2022-2024): Subvariant Tracking and Assessment of Regional Sequencing Efforts.
Souza U, Spilki F, Tanuri A, Roehe P, Campos F
Viruses. 2025; 17(1).
PMID: 39861853
PMC: 11768930.
DOI: 10.3390/v17010064.
Leveraging dynamics informed neural networks for predictive modeling of COVID-19 spread: a hybrid SEIRV-DNNs approach.
Cheng C, Aruchunan E, Noor Aziz M
Sci Rep. 2025; 15(1):2043.
PMID: 39814760
PMC: 11735935.
DOI: 10.1038/s41598-025-85440-1.
Clinical and epidemiological characteristics and outcomes of patients affected by COVID-19 in the Intensive Care Unit.
Timoteo P, Medeiros K, Tourinho F
Rev Bras Enferm. 2025; 77Suppl 1(Suppl 1):e20230527.
PMID: 39813429
PMC: 11726807.
DOI: 10.1590/0034-7167-2023-0527.
Strategies Used by SARS-CoV-2 to Evade the Innate Immune System in an Evolutionary Perspective.
Fan H, Tian M, Liu S, Ye C, Li Z, Wu K
Pathogens. 2025; 13(12.
PMID: 39770376
PMC: 11677916.
DOI: 10.3390/pathogens13121117.
Phenotypic evolution of SARS-CoV-2 spike during the COVID-19 pandemic.
Furnon W, Cowton V, De Lorenzo G, Orton R, Herder V, Cantoni D
Nat Microbiol. 2025; 10(1):77-93.
PMID: 39753670
PMC: 11726466.
DOI: 10.1038/s41564-024-01878-5.
Systematic surveillance of SARS-CoV-2 reveals dynamics of variant mutagenesis and transmission in a large urban population.
Aynaud M, Caldwell L, Al-Zahrani K, Barutcu S, Chan K, Obersterescu A
Nat Commun. 2024; 15(1):10795.
PMID: 39738001
PMC: 11685962.
DOI: 10.1038/s41467-024-55031-1.
Effect of COVID-19 infection on thyroid function status and clinical indexes among hypothyroid outpatients.
Li B, Feng X, Zhang Y, Huang Y, Gu M, Sun H
Virulence. 2024; 16(1):2441397.
PMID: 39727211
PMC: 11702938.
DOI: 10.1080/21505594.2024.2441397.
Environmental predictors of SARS-CoV-2 infection incidence in Catalonia (northwestern Mediterranean).
Planella-Morato J, Pelegri J, Martin-Rey M, Olive Abello A, Valles X, Roca J
Front Public Health. 2024; 12:1430902.
PMID: 39703486
PMC: 11656081.
DOI: 10.3389/fpubh.2024.1430902.
Navigating the COVID-19 Therapeutic Landscape: Unveiling Novel Perspectives on FDA-Approved Medications, Vaccination Targets, and Emerging Novel Strategies.
Barghash R, Gemmati D, Awad A, Elbakry M, Tisato V, Awad K
Molecules. 2024; 29(23.
PMID: 39683724
PMC: 11643501.
DOI: 10.3390/molecules29235564.
Frequency dynamics predict viral fitness, antigenic relationships and epidemic growth.
Figgins M, Bedford T
medRxiv. 2024; .
PMID: 39677467
PMC: 11643185.
DOI: 10.1101/2024.12.02.24318334.
High resistance barrier and prophylactic protection in preclinical models of SARS-CoV-2 with two siRNA combination.
Anglero-Rodriguez Y, Lempp F, Subramanian M, McIninch J, Schlegel M, Bohan D
Nucleic Acids Res. 2024; 53(1.
PMID: 39657790
PMC: 11724309.
DOI: 10.1093/nar/gkae1195.
Higher frequency of interstate over international transmission chains of SARS-CoV-2 virus at the Rio Grande do Sul - Brazil state borders.
Dezordi F, Silva Junior J, Ruoso T, Batista A, Fonseca P, Bernardo L
Virus Res. 2024; 351():199500.
PMID: 39645167
PMC: 11720880.
DOI: 10.1016/j.virusres.2024.199500.
Analytical Performance of a Novel Nanopore Sequencing for SARS-CoV-2 Genomic Surveillance.
Maimaiti M, Kong L, Yu Q, Wang Z, Liu Y, Yang C
J Med Virol. 2024; 96(12):e70108.
PMID: 39639823
PMC: 11621993.
DOI: 10.1002/jmv.70108.
Research progress of spike protein mutation of SARS-CoV-2 mutant strain and antibody development.
Huan X, Zhan J, Gao H
Front Immunol. 2024; 15:1407149.
PMID: 39624100
PMC: 11609190.
DOI: 10.3389/fimmu.2024.1407149.
Clinical Characteristics and Outcomes of Hospitalized COVID-19 Patients with Different Variants of SARS-CoV-2 in a Tertiary Care Hospital, Thailand.
Hengkrawit K, Thananon J, Telapol K, Chiewchalermsri C
Trop Med Infect Dis. 2024; 9(11).
PMID: 39591272
PMC: 11598002.
DOI: 10.3390/tropicalmed9110266.